Search clinical trials for: ASA404, DMXAA, DXAA

Total 194 results

Novartis Pharmaceuticals

Terminated

A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function

Metastatic Cancer

United States
Novartis Pharmaceuticals

Terminated

A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies

Solid Tumor Malignancies

United States
Cancer Research UK
Cancer Society Auckland

Completed

Study of DMXAA (Now Known as ASA404) in Solid Tumors (DMXAA)

Solid Tumors
University of Memphis
University of Tennessee Health Science Center; USP Labs, Inc.

Completed

Pharmacokinetic Effects of Oral DMAA

Outcomes of Single Oral Dose

United States
Antisoma Research

Completed

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Prostate Cancer

United States
Antisoma Research

Completed

Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer
University of California, San Francisco
Novartis Pharmaceuticals

Withdrawn

ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors

Tumors

United States
Antisoma Research

Completed

Phase I Safety Study of DMXAA in Refractory Tumors (DART)

Refractory Tumors
Novartis Pharmaceuticals

Completed

An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Japan
Novartis Pharmaceuticals

Terminated

An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function

Histologically-proven and Radiologically-confirmed Solid Tumors

Italy, New Zealand
Novartis Pharmaceuticals

Terminated

An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404

Metastatic Cancer With Impaired Renal Function | Metastatic Cancer With Normal Renal Function

Belgium
Novartis Pharmaceuticals

Completed

Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors

Advanced or Recurrent Solid Tumors

Japan
Ascletis Pharmaceuticals Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

China
Novartis Pharmaceuticals

Terminated

A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors

Advanced Solid Tumors

New Zealand
Korean Pharmacoacupuncture Institute

Unknown

East-West Collaborative Medicine Using Bee-Venom Acupuncture on Whiplash-Associated Disorders

Whiplash Injuries
Novartis Pharmaceuticals

Terminated

Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor

Solid Tumors

United States
Ascletis Pharmaceuticals Co., Ltd.

Not yet recruiting

A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris

Acne
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Mini- Open Direct-anterior Approach vs Hip Arthroscopy for Treatment of Femoroacetabular Impingement.

Femoracetabular Impingement

Belgium
Tongji Hospital

Unknown

To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI

Chronic Kidney Disease-Mineral and Bone Disorder

China
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris

Acne

China
Hoosier Cancer Research Network
Novartis Pharmaceuticals

Withdrawn

Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma

Urothelial Carcinoma
Kirilys Therapeutics Inc.

Active, not recruiting

Study of ASN004 in Patients With Advanced Solid Tumors (ASN004)

Solid Tumor

United States
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Recruiting

Analysis of Defined Elements on DXA in Patients Undergoing Hip Arthroplasty (THA_DXA)

Bone Resorption | Arthroplasty Complications

Italy
Levita Magnetics
The Cleveland Clinic

Recruiting

Prospective, Multi-center, Single-arm, Open Label Study Designed to Assess the Safety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic Procedures (MARS GI)

Bariatric Surgery Candidate | Cholelithiases | Other Disease

Chile
Sheffield Children's NHS Foundation Trust
University of Sheffield

Completed

Developing a COMputerised Bone Age Tool (COMBAT1)

Bone Diseases, Developmental

United Kingdom
Antisoma Research

Completed

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Metastatic Renal Cell Carcinoma | Metastatic Malignant Melanoma

United Kingdom, New Zealand
Swiss Paraplegic Research, Nottwil

Completed

Bone Strength After Spinal Cord Injury

Spinal Cord Injury

Switzerland
Centre Hospitalier Universitaire de Nīmes
DMS Apelem

Active, not recruiting

Evaluation of Agreement Between CT Scan and 3D-DXA Measurements on the Lombar Spine (3D DXA SPINE)

Bone Fracture

France
State University of New York - Upstate Medical...

Completed

Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers

Regional Osteoporosis as a Result of Chemotherapy

United States
Novartis Pharmaceuticals

Terminated

A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer (ATTRACT-2)

Non-Small Cell Lung Cancer

United States, Germany, Belgium, Italy, France, Canada, Hungary, Poland, Switzerland, Spain
Assiut University

Not yet recruiting

The Relationship Between Rheumatoid Arthritis and Osteoporosis and Factors Contributing to This Connection

RA & OP Relationship
Novartis Pharmaceuticals

Terminated

ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer (ATRACT-1)

Non-Small Cell Lung Cancer

United States, Greece, Hong Kong, Taiwan, Argentina, Germany, United Kingdom, Singapore, Italy, Spain, France, Korea, Republic of, Netherlands, Brazil, Canada, Turkey, China, New Zealand, Hungary, Poland, Australia, Japan, Israel, Bel... and more
Dionyssiotis, Yannis, M.D.
University of Thessaly

Completed

Sarcopenia and Diabetes Mellitus (SARCoDM)

Sarcopenia

Greece
Jens Rikardt Andersen
Hillerod Hospital, Denmark

Completed

Body Composition Measurements in Pneumonia

Acute Infection Respiratory

Denmark
National University Hospital, Singapore

Completed

A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects (DAA-I)

Healthy
Central Hospital, Nancy, France

Unknown

Bone Fragility Evaluation in Obese Patients

Obesity | Bariatric Surgery Candidate

France
Herlev Hospital
Danish Cancer Society

Completed

Quality of Life and Surgical Late Effects of Melanoma Treatment

Depression | Melanoma | Quality of Life | Pain | Cicatrix | Lymphedema | Anxiety

Denmark
Dionyssiotis, Yannis, M.D.
University of Athens; University of Patras

Completed

Sarcopenic Obesity in Neurodisabilities (SarcObeNDS)

Stroke | Multiple Sclerosis | Traumatic Brain Injury | Spinal Cord Injuries | Sarcopenic Obesity

Greece
Baxalta now part of Shire

Terminated

Osteoporosis and MRI Study in Hemophilia

Hemophilia A | Hemophilia B | Bone Mineral Density

United States
Erasmus Medical Center
ISA Pharmaceuticals B.V.

Recruiting

Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 (HEB-PEP)

Chronic Hepatitis b

Netherlands
Azienda Ospedaliera Universitaria Integrata Verona

Recruiting

Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial) (FRAIL)

Lupus Erythematosus, Systemic

Italy
Odense University Hospital
University of Southern Denmark; University Hospital Schleswig-Holstein

Completed

Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE) (ROSE)

Osteoporosis

Denmark
University Hospital, Clermont-Ferrand

Unknown

Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease (PAFOS)

Parkinson's Disease

France
Ottawa Hospital Research Institute
MicroPort Orthopedics Inc.

Recruiting

Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches

Arthroplasty, Replacement, Hip

Canada
George Washington University
National Institutes of Health (NIH); Children's National Research Institute

Completed

Muscle Ultrasound for Sarcopenia Leading to Early Detection (MUSCLED)

Sarcopenia

United States
Göteborg University
Sophiahemmet University

Recruiting

CLIMB: Climbers' Longitudinal Attitudes to Injuries, Mental Health and Body Image

Musculoskeletal Pain | Eating Disorders | Mental Health Issue | Relative Energy Deficiency in Sport

Sweden
Penn State University

Recruiting

DXA Study of Precision and Reliability

Body Composition | Bone and Bones

United States
Arthrex, Inc.

Recruiting

Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

Full-thickness Rotator Cuff Tear

United States
Universidad de Valparaiso
Pontificia Universidad Catolica de Valparaiso; Centro Gerópolis UV, Valparaíso and other collaborators

Recruiting

Cortical Bone Assessment Using Ultrasonic Guided Waves: Towards a Robust Clinical Measurement (BDATChile)

Osteoporotic Fractures

Chile
Tri-Service General Hospital

Completed

Sarcopenia and Osteoporosis in the Patients With Hemophilia

Hemophilia | Sarcopenia | Hemophilic Arthropathy | Osteoporosis, Osteopenia

Taiwan

Search clinical trials for: ASA404, DMXAA, DXAA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations